Zobrazeno 1 - 10
of 52
pro vyhledávání: '"U A Brel'"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 2, Iss 1, Pp 27-30 (2016)
Aim. To assess antihypertensive efficacy of rilmenidine (Albarel, EGIS, Hungary) and its effect on cognitive function in elderly hypertensive patients. Material and methods. 30 elderly (in average 68 y.o.) hypertensive patients were observed. Each pa
Externí odkaz:
https://doaj.org/article/e36a8c8488074b50bb279c318d955cdc
Autor:
S. V. Nedogoda, I. N. Barykina, U. A. Brel, T. A. Chalyabi, G. V. Mazina, E. V. Podolskaya, A. A. Ledyaeva
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 8, Iss 4, Pp 23-27 (2009)
Aim. To investigate the potential of sibutramine (Meridia®) therapy in patients with obesity and arterial hypertension (AH); to assess sibutramine effects on blood pressure (BP), organ protection and quality of life (QoL) in individuals with obesity
Externí odkaz:
https://doaj.org/article/f2d71704503e42129b0400e63ad630a0
Autor:
Sergey Vladimirovich Nedogoda, I N Barykina, U A Brel', T A Chalyabi, G V Mazina, E V Podol'skaya, A A Ledyaeva
Publikováno v:
Системные гипертензии, Vol 6, Iss 2, Pp 47-50 (2009)
Externí odkaz:
https://doaj.org/article/551e7d452c1247bd9666cd575077bec3
Autor:
S. V. Nedogoda, I. N. Barykina, T. A. Chalyabi, L. V. Butrina, U. A. Brel, G. V. Mazina, E. A. Podolskaya
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 8, Iss 1, Pp 88-98 (2009)
The review is devoted to the features of antihypertensive therapy (AHT) in arterial hypertension combined with obesity. Pathogenesis of blood pressure increase in obesity is emphasised. The authors analyse the safety of various antihypertensive medic
Externí odkaz:
https://doaj.org/article/e91d40c56ee349228476b69fb19bace1
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 7, Iss 6, Pp 21-27 (2008)
Aim. To assess the effectiveness of fixed-dose combination of enalapril maleate (20 mg) and hydrochlorothiazide (12,5 mg) - Enap NL 20, comparing to arbitrary combinations of two antihypertensive medications (АНМ), in patients with Stage I-III art
Externí odkaz:
https://doaj.org/article/aa0bb398964e463386d4da1e14c82dce
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 7, Iss 5, Pp 105-115 (2008)
The review is devoted to the problem of arterial hypertension (AH) combined with obesity. Pharmaceutical and non-pharmaceutical methods for weight reduction, as well as their effects on blood pressure (BP), are emphasised. Sibutramine safety in AH an
Externí odkaz:
https://doaj.org/article/6485bee6d72045149af66b4ad0d8164f
Autor:
S V Nedogoda, I N Barykina, U A Brel', T A Chalyabi, G V Mazina, E V Podol'skaya, D A Zaremba
Publikováno v:
Системные гипертензии, Vol 5, Iss 3, Pp 66-71 (2008)
Externí odkaz:
https://doaj.org/article/ed6e9eb703424edd9b68a19b6d423d54
Autor:
S V Nedogoda, U A Brel'
Publikováno v:
Системные гипертензии, Vol 5, Iss 2, Pp 23-28 (2008)
Externí odkaz:
https://doaj.org/article/8e78be5b333a4958a176980f7fe91fb1
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 6, Iss 6, Pp 10-14 (2007)
Aim. To compare clinical effectiveness and tolerability of original (Cozaar®) and generic (Lozap®) losartan in high and very high-risk patients with Stage I-II arterial hypertension (AH). Material and methods. This blind, randomized (envelope metho
Externí odkaz:
https://doaj.org/article/d9df7160c50047788b246194dda17892
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 6, Iss 3, Pp 11-18 (2007)
Aim. To assess and compare 6-month monotherapy effectiveness for losartan and lisinopril, according to their effects on blood pressure (BP), vascular elasticity, and cognitive function in patients with Stage I-II arterial hypertension (AH). Material
Externí odkaz:
https://doaj.org/article/ae4fd389eb1f4c62bd3f592669c629e0